Pfizer Inc. (PFE), the world’s largest drugmaker, gained the most in three months after Goldman Sachs analysts said the company may go beyond the divestiture plans it has already announced.
Pfizer climbed 2.5 percent to $22.72 at 10:57 a.m., after earlier rising to $22.80. The shares have increased 9.2 percent since July 6, the day before Pfizer Chief Executive Officer Ian Read said the New York-based company was exploring strategic alternatives for its animal health and nutrition businesses.
Read, at a recent meeting with Goldman analysts, indicated he may be willing to further split up the company after selling or spinning off those two units, Jami Rubin, a Goldman Sachs analyst, wrote in a note to investors.
“We see these moves as first steps in a potential full- scale breakup,” akin to the split-up now taking place at Abbott Laboratories (ABT), Rubin wrote.
Tuesday, March 27, 2012
Pfizer Rises After Goldman Raises Possibility of Full Breakup - Bloomberg
>via bloomberg.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment